BRPI1008849B8 - dispositivo médico e método para controle glicêmico - Google Patents

dispositivo médico e método para controle glicêmico

Info

Publication number
BRPI1008849B8
BRPI1008849B8 BRPI1008849A BRPI1008849A BRPI1008849B8 BR PI1008849 B8 BRPI1008849 B8 BR PI1008849B8 BR PI1008849 A BRPI1008849 A BR PI1008849A BR PI1008849 A BRPI1008849 A BR PI1008849A BR PI1008849 B8 BRPI1008849 B8 BR PI1008849B8
Authority
BR
Brazil
Prior art keywords
dose
glycemic
medical device
predetermined
blood glucose
Prior art date
Application number
BRPI1008849A
Other languages
English (en)
Inventor
Tubb Andrew
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI1008849A2 publication Critical patent/BRPI1008849A2/pt
Publication of BRPI1008849B1 publication Critical patent/BRPI1008849B1/pt
Publication of BRPI1008849B8 publication Critical patent/BRPI1008849B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

dispositivo médico e método para controle glicêmico. a presente invenção refere-se a um dispositivo e método médicos que servem para determinar uma dose de insulina a ser administrada para controle glicêmico, em que a dose é gradualmente adaptada, compreendendo determinar um valor de glicose sanguínea, receber informações de evento glicêmico em relação a um evento glicêmico predeterminado, em que o evento glicêmico predeterminado ocorreu dentro de um intervalo de tempo predeterminado, receber um valor de dosagem previamente adaptado armazenado em uma unidade de armazenamento, e ajustar um alerta com base pelo menos no valor de glicose sanguínea, nas informações de evento glicêmico e na dose previamente adaptada, em que o alerta indica que o valor de glicose sanguínea e o evento glicêmico predeterminado não se encontram em uma relação específica ao valor de dosagem previamente adaptado.
BRPI1008849A 2009-02-04 2010-02-03 dispositivo médico e método para controle glicêmico BRPI1008849B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09001564 2009-02-04
EP09001564.5 2009-02-04
PCT/EP2010/051266 WO2010089305A1 (en) 2009-02-04 2010-02-03 Medical device and method for glycemic control

Publications (3)

Publication Number Publication Date
BRPI1008849A2 BRPI1008849A2 (pt) 2016-03-15
BRPI1008849B1 BRPI1008849B1 (pt) 2020-11-24
BRPI1008849B8 true BRPI1008849B8 (pt) 2021-06-22

Family

ID=40637182

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008849A BRPI1008849B8 (pt) 2009-02-04 2010-02-03 dispositivo médico e método para controle glicêmico

Country Status (14)

Country Link
US (1) US11166650B2 (pt)
EP (1) EP2393413B1 (pt)
JP (1) JP5818691B2 (pt)
CN (1) CN102369031B (pt)
AU (1) AU2010210155B2 (pt)
BR (1) BRPI1008849B8 (pt)
CA (1) CA2750317C (pt)
DK (1) DK2393413T3 (pt)
ES (1) ES2558699T3 (pt)
HK (1) HK1164081A1 (pt)
HU (1) HUE026102T2 (pt)
IL (1) IL214315A (pt)
PL (1) PL2393413T3 (pt)
WO (1) WO2010089305A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
PT2260423T (pt) 2008-04-04 2018-05-30 Hygieia Inc Aparelho para optimizar o regime de dosagem de insulina a um paciente
US10624577B2 (en) 2008-04-04 2020-04-21 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
WO2010056718A2 (en) 2008-11-11 2010-05-20 Hygieia, Inc. Apparatus and system for diabetes management
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
KR101529407B1 (ko) 2008-12-23 2015-06-16 에프. 호프만-라 로슈 아게 수집 디바이스 상에서 구동하는 구조화된 수집 절차의 구현, 실행, 데이터 수집, 및 데이터 분석을 위한 관리 방법 및 시스템
US8849458B2 (en) 2008-12-23 2014-09-30 Roche Diagnostics Operations, Inc. Collection device with selective display of test results, method and computer program product thereof
US10456036B2 (en) 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
US10136845B2 (en) * 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
AR092077A1 (es) * 2012-08-10 2015-03-18 Sanofi Aventis Deutschland Sistema medico
US9730621B2 (en) * 2012-12-31 2017-08-15 Dexcom, Inc. Remote monitoring of analyte measurements
US9585563B2 (en) 2012-12-31 2017-03-07 Dexcom, Inc. Remote monitoring of analyte measurements
DE102013001181A1 (de) * 2013-01-24 2014-07-24 Dräger Medical GmbH Gasanalyse-, Beatmungs- oder Anästhesiegerät mit Bedienungsführung
US9710604B2 (en) * 2013-06-27 2017-07-18 Lifescan, Inc. Analyte meter with operational range configuration technique
WO2015026837A1 (en) 2013-08-20 2015-02-26 Baxter International Inc. Device for encouraging adherence to medication schedule and proper administration technique
US9384397B2 (en) 2013-08-22 2016-07-05 Ut-Battelle, Llc Model for mapping settlements
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US10321859B1 (en) * 2014-02-25 2019-06-18 Glooko Inc. Systems and methods for capturing and analyzing hypoglycemic event data
EP2966582A1 (en) * 2014-07-11 2016-01-13 Sanofi-Aventis Deutschland GmbH Titration of basal insulin with two modes
US10002235B2 (en) * 2014-08-13 2018-06-19 Ivenix, Inc. Medical device management and theft inhibitor techniques
CA2956255C (en) * 2014-09-15 2020-01-28 F. Hoffmann-La Roche Ag A method for generating a monitoring signal using a supervising entity or safety module
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
CA2927335C (en) 2014-10-27 2023-05-02 Aseko, Inc. Subcutaneous outpatient management
CA2993275C (en) 2015-08-20 2022-06-21 Aseko, Inc. Diabetes management therapy advisor
US11032855B2 (en) 2016-10-18 2021-06-08 Dexcom, Inc. System and method for communication of analyte data
US11019411B2 (en) * 2016-10-18 2021-05-25 Dexcom, Inc. System and method for communication of analyte data
KR102486823B1 (ko) * 2016-10-19 2023-01-10 삼성전자주식회사 혈당 관리 서비스를 제공하기 위한 전자 장치 및 방법
US11457863B1 (en) 2017-10-27 2022-10-04 Verily Life Sciences Llc Virtual health coach based insulin titration platform
US11967407B2 (en) 2018-07-26 2024-04-23 Sanofi Method of adjusting medication doses
MX2022000669A (es) 2019-07-16 2022-08-22 Beta Bionics Inc Sistema de control de glucosa en sangre.
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
CN114730621A (zh) * 2019-12-03 2022-07-08 诺和诺德股份有限公司 针对剂量指导算法的自我基准测试
US20220189601A1 (en) * 2020-12-07 2022-06-16 Beta Bionics, Inc. Modular blood glucose control systems
CN116721733B (zh) * 2023-08-10 2023-11-07 武汉联影智融医疗科技有限公司 血糖值调整方法、装置和存储介质

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7448375B2 (en) * 1993-01-29 2008-11-11 Aradigm Corporation Method of treating diabetes mellitus in a patient
US7006871B1 (en) * 1997-07-16 2006-02-28 Metacure N.V. Blood glucose level control
US20080076997A1 (en) * 1998-04-30 2008-03-27 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US20040249421A1 (en) * 2000-09-13 2004-12-09 Impulse Dynamics Nv Blood glucose level control
US9006175B2 (en) * 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6923763B1 (en) 1999-08-23 2005-08-02 University Of Virginia Patent Foundation Method and apparatus for predicting the risk of hypoglycemia
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
AU2003236201A1 (en) * 2002-05-07 2003-11-11 Novo Nordisk A/S Soluble formulations comprising monomeric insulin and acylated insulin
US7404796B2 (en) * 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
US7016720B2 (en) * 2002-10-21 2006-03-21 Pacesetter, Inc. System and method for monitoring blood glucose levels using an implantable medical device
US20050038680A1 (en) * 2002-12-19 2005-02-17 Mcmahon Kevin Lee System and method for glucose monitoring
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
CN101410146A (zh) * 2003-04-18 2009-04-15 因苏雷特公司 输液泵遥控器的用户接口及其使用方法
DE10325106A1 (de) * 2003-06-03 2004-12-30 Disetronic Licensing Ag Vorrichtung und Verfahren zur Erkennung eines Benutzers eines medizinischen Geräts
JP2007535974A (ja) * 2004-03-26 2007-12-13 ノボ・ノルデイスク・エー／エス 糖尿病患者の関連データの表示装置
US7651845B2 (en) 2004-05-13 2010-01-26 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
JP5037496B2 (ja) 2005-05-13 2012-09-26 トラスティーズ オブ ボストン ユニバーシティ １型糖尿病用の完全自動制御システム
US20070233051A1 (en) * 2006-03-31 2007-10-04 David Hohl Drug delivery systems and methods
US8579853B2 (en) * 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
WO2008057384A2 (en) * 2006-11-02 2008-05-15 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate
US20080306353A1 (en) * 2006-11-03 2008-12-11 Douglas Joel S Calculation device for metabolic control of critically ill and/or diabetic patients
US10154804B2 (en) * 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
WO2008103827A1 (en) * 2007-02-22 2008-08-28 Welldoc Communications, Inc. System and method for providing treatment recommendations based on models
US8260558B2 (en) * 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
ES2733350T3 (es) 2007-06-27 2019-11-28 Hoffmann La Roche Sistema para el diagnóstico, tratamiento y pronóstico médicos para acontecimientos solicitados y procedimiento del mismo
US8019410B1 (en) * 2007-08-22 2011-09-13 Pacesetter, Inc. System and method for detecting hypoglycemia using an implantable medical device based on pre-symptomatic physiological responses
US9918635B2 (en) * 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage

Also Published As

Publication number Publication date
WO2010089305A1 (en) 2010-08-12
JP2012516733A (ja) 2012-07-26
CN102369031A (zh) 2012-03-07
CN102369031B (zh) 2015-11-25
AU2010210155A1 (en) 2011-08-25
BRPI1008849B1 (pt) 2020-11-24
BRPI1008849A2 (pt) 2016-03-15
HK1164081A1 (en) 2012-09-21
DK2393413T3 (en) 2016-01-18
PL2393413T3 (pl) 2016-04-29
AU2010210155B2 (en) 2015-04-09
IL214315A (en) 2014-12-31
CA2750317A1 (en) 2010-08-12
JP5818691B2 (ja) 2015-11-18
ES2558699T3 (es) 2016-02-08
US20120116196A1 (en) 2012-05-10
EP2393413A1 (en) 2011-12-14
CA2750317C (en) 2016-10-25
EP2393413B1 (en) 2015-10-14
HUE026102T2 (en) 2016-05-30
IL214315A0 (en) 2011-09-27
US11166650B2 (en) 2021-11-09

Similar Documents

Publication Publication Date Title
BRPI1008849B8 (pt) dispositivo médico e método para controle glicêmico
BR112015026736A2 (pt) método, aparelho, mídia de armazenamento não transitório, programa de computador, e, sinal
BR112014019386A8 (pt) Dispositivo suplementar para a fixação a um dispositivo de injeção
BR112015014941A2 (pt) método e sistema para um controle previsivo de modelo controle-para-alvo híbrido e controle-para-faixa de um pâncreas artificial
Colberg et al. Blood glucose responses to type, intensity, duration, and timing of exercise
BR112012020270A2 (pt) sistema e método para administrar medicamentos com base em valores de urina.
BR112014029588A2 (pt) sistema e métodos para detectar distúrbios de saúde
BRPI0817925B8 (pt) sistema para monitorar e regular níveis de glicose no sangue em uma corrente sanguínea
MX2016006252A (es) Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono.
BRPI0804600A2 (pt) interface do usuário para dispositivo de infusão de insulina
MX351045B (es) Equipo de combinación de dosis de seguridad y jeringa de seguridad.
BR112014032912A2 (pt) método e sistema para administrar bolus manuais ou eventos de refeição em controladores de circuito fechado
BR122022000127A8 (pt) Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagem
HK1146118A1 (en) Blood glucose level measuring system
BR112012022801B8 (pt) método de identificar um indivíduo que tem câncer que é provável beneficiar-se do tratamento com uma terapia de combinação com um inibidor de raf e um segundo inibidor e uso de um inibidor de raf e um segundo inibidor para a fabricação de um medicamento para tratar câncer
BR112015008222A2 (pt) sistema e método para a monitoração e o controle de um estado de um paciente durante e após a administração de um composto anestésico
BR112015005768A2 (pt) aparelho de análise da atividade uterina; método para renderizar o conteúdo relacionado à atividade uterina de um paciente; e programa de computador armazenado em um meio de memória não transitória legível por computador
BR112017021298A2 (pt) sistemas, mídia de armazenamento não transitório, e método
BR112015000830A2 (pt) sistema para prover terapia respiratória a um indivíduo que possui vias aéreas, método para determinação da aderência em relação à terapia respiratória de um indivíduo que possui vias aéreas, e sistema configurado para prover terapia respiratória a um indivíduo que possui vias aéreas
BR112014000113A2 (pt) sistema e método para prever a viabilidade de um tecido corporal em um paciente e dispositivo de medição para medir a pressão de perfusão local em um tecido corporal de um paciente
Basile-Filho et al. The use of perioperative serial blood lactate levels, the APACHE II and the postoperative MELD as predictors of early mortality after liver transplantation
CU23940B1 (es) Dispositivo indicador para un distribuidor de dosis de medicamentos
BR112013029645A2 (pt) Diagnóstico de doença de infecção respiratória usando amostras de sangue
Kranke et al. Cardiac arrest and remifentanil PCA.
Palandi et al. Aspects of speech of subjects with cleft palate corrected in different ages

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/11/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/02/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO